02633.HK
Jacobson Pharma Corporation Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.94
−1.06%Year over year
Reported trailing growth
- Revenue
- -0.5%
- EBITDA
- -7.6%
- EBIT
- -2.8%
- EPS
- -0.4%
- Free cash flow
- -46.1%
- Operating cash flow
- -37.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.2%
- EBITDA
- +3.1%
- EBIT
- +3.4%
- Net income
- +6.3%
- EPS
- +4.9%
- Free cash flow
- -30.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026